Logout successfull!
History of BIOLOX®delta
2002
First 6 mm ZTA Ceramic Hemi Unicondylar Arthroplasty1

Implanted by Jonathan Garino MD1

Beyond
Hip

Wide acceptance of this ceramic technology in hip joint replacement has led to the development of yet another generation of alumina ceramics, that being zirconia toughened alumina, which will likely set the new standard in ceramic-ceramic articulations.

This material with its increased strength, may allow for more complex reconstructions in and around the hip to take place with ceramic-ceramic articulations previously reserved exclusively for the metal-polyethylene combination.

In addition, our confidence in this material combined with modern technologies would lead the use of ceramic components beyond the hip into the knee and find applications elsewhere in orthopaedics.1

Johnathan Garino MD – April 2002

2003
FDA Clearance

Granted for the use of BIOLOX®delta ceramic heads in the United States for one US customer

2005
BIOLOX®OPTION

Release and introduction of sleeved ceramic heads

2006
Inauguration of Marktredwitz Plant

A second manufacturing plant for BIOLOX® hip implants in Bavaria, Germany, goes into production

2006
Release and Introduction of the First BIOLOX®delta Knee System in Europe

MULTIGEN Delta Knee (LIMA Corporate)

2010
BIOLOX®delta

FDA clearance for the use of delta-delta hip bearing in the United States

2011
Second BIOLOX®delta Knee in Europe

Release and introduction
BPK-S Ceramic knee
Peter Brehm GmbH

2012
BIOLOX®delta

Release and introduction of the XLW Zero liners

2015
Extension of Manufacturing Capacities

In Marktredwitz, Bavaria, Germany

A Beneficial
Choice

Current best available evidence from international joint registries gives strong indications and tendencies that BIOLOX®delta bearings (CoC and CoP) in THA are associated with a lower overall risk of revision, mainly driven by a lower risk of revision for periprosthetic joint infection.

Cumulative 2-to-13-year survival of THAs with BIOLOX®delta bearings range from 94 to 100%, accompanied by significant improvements in function and pain comparable to other couplings.

This comprehensive review suggests a favourable benefit-risk-ratio of ceramic bearings (CoC and CoP) compared to other couplings in total hip arthroplasty (THA). While the lack of confirmatory evidence from large-scale randomized controlled trials (RCTs) cannot and must not be denied, registry data speak a clear language.2


Dirk Stengel MD, PhD, MSc, CeraNews 2022

2015
Implantation of a Patient-Specific Shoulder

For the first US customer

2017
Start of a Clinical
Study by Embody Orthopaedic Limited

Using the H1 Ceramic-on-Ceramic Resurfacing made of BIOLOX®delta

2018
Cellular Ceramic Made of ZTA CERAMIC

Ceramic foam technology

2019
BIOLOX CONTOURA®

FDA clearance granted for the contoured femoral head for TJO Inc.

 
2022
The BIOLOX®CERAMIC KNEE System

Breakthrough Device Designation Granted to CeramTec by the FDA

Read more about the ceramic knee

Learn More About Our Products and Solutions

1. Garino J. P, Willmann G. et al. Bioceramics in Joint Arthroplasty - Proceedings 7th International BIOLOX® Symposium March 15-16 2002, Thieme Verlag, Stuttgart. © held by CT (Corporate driven publication with Thieme).​

2. Stengel D. — CeraNews 2022